Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | RET | P07949 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | TOP2A | P11388 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.46 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.46 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.46 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9746611 | 1.00 | KMT2A (0.81) | KMT2ASMN1; SMN2RETNPC1RAB9A | |
| SCHEMBL13263852 | 1.00 | KMT2A (0.81) | KMT2ASMN1; SMN2RETNPC1RAB9A | |
| SCHEMBL28437309 | 1.00 | KMT2A (0.81) | KMT2ASMN1; SMN2RETNPC1RAB9A | |
| SCHEMBL3172173 | 0.98 | KMT2A (0.84) | KMT2ASMN1; SMN2RETNPC1RAB9A | |
| SCHEMBL7285233 | 0.94 | KMT2A (0.81) | KMT2ASMN1; SMN2RETALDH1A1LMNA | |
| SCHEMBL5386778 | 0.93 | KMT2A (0.70) | KMT2ASMN1; SMN2RETALDH1A1LMNA | |
| SCHEMBL14575820 | 0.90 | KMT2A (1.00) | KMT2ASMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL15430731 | 0.89 | KMT2A (0.65) | KMT2ASMN1; SMN2RETNPC1RAB9A | |
| SCHEMBL5696854 | 0.88 | KMT2A (0.68) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL38661498 | 0.88 | KMT2A (0.68) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116556083-B | Polyester cotton short-process dyeing process | 浙江红绿蓝纺织印染有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-116556083-A | Polyester cotton short-process dyeing process | 浙江红绿蓝纺织印染有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116556083-B | Polyester cotton short-process dyeing process | 浙江红绿蓝纺织印染有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-116556083-A | Polyester cotton short-process dyeing process | 浙江红绿蓝纺织印染有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-108047105-B | 3-/4-ester-group-substituted benzaldehyde thiosemicarbazone derivative and preparation and application thereof | 广东轻工职业技术学院 | 2020-06-26 | — | — | CN | disclosed |
| CN-108047105-A | 3-/4- ester group substituted benzaldehyde thiosemicarbazone derivatives and its preparation and application | 广东轻工职业技术学院 | 2018-05-18 | — | — | CN | disclosed |
| EP-2493905-B1 | BISPHOSPHONATE COMPOUNDS FOR TREATING BONE METABOLISM DISORDERS | WARNER CHILCOTT CO LLC (PR) | 2016-11-30 | — | — | EP | disclosed |
| EP-2493905-B1 | BISPHOSPHONATE COMPOUNDS FOR TREATING BONE METABOLISM DISORDERS | WARNER CHILCOTT CO LLC (PR) | 2016-11-30 | — | — | EP | disclosed |
| US-8822435-B2 | Bisphosphonate compounds | WARNER CHILCOTT COMPANY, LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-8822435-B2 | Bisphosphonate compounds | WARNER CHILCOTT COMPANY, LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-8822435-B2 | Bisphosphonate compounds | WARNER CHILCOTT COMPANY, LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-20110098251-A1 | BISPHOSPHONATE COMPOUNDS | WARNER CHILCOTT COMPANY, LLC (US) | 2011-04-28 | — | — | US | disclosed |
| US-20110098251-A1 | BISPHOSPHONATE COMPOUNDS | WARNER CHILCOTT COMPANY, LLC (US) | 2011-04-28 | — | — | US | disclosed |
| US-20110098251-A1 | BISPHOSPHONATE COMPOUNDS | WARNER CHILCOTT COMPANY, LLC (US) | 2011-04-28 | — | — | US | disclosed |
| EP-0152217-B1 | LIQUID CRYSTALLINE CARBONIC ACID ESTERS AND LIQUID CRYSTAL COMPOSITIONS CONTAINING THEM | Chisso Corporation (JP) | 1990-08-29 | — | — | EP | disclosed |
| EP-0153826-B1 | LIQUID-CRYSTALLINE SUBSTITUTED BIPHENYL ESTERS | Chisso Corporation (JP) | 1990-06-13 | — | — | EP | disclosed |
| US-4737313-A | OPITICALLY ACTIVE | CHISSO CORPORATION (JP) | 1988-04-12 | — | — | US | disclosed |
| US-4647398-A | Liquid-crystalline carbonic acid esters and liquid crystal compositions containing same | CHISSO CORPORATION (JP) | 1987-03-03 | — | — | US | disclosed |
| EP-0153826-A2 | Liquid-crystalline substituted biphenyl esters | Chisso Corporation (JP) | 1985-09-04 | — | — | EP | disclosed |
| EP-0152217-A2 | Liquid crystalline carbonic acid esters and liquid crystal compositions containing them | Chisso Corporation (JP) | 1985-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098251-A1 | BISPHOSPHONATE COMPOUNDS | BPGM, PPIP5K2, PTEN | KMT2A 4240/4885SMN1; SMN2 2670/4885RET 3776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.